Skip to main content
MedPathMedPath Home
Clinical Trials/NCT00060931
NCT00060931
Completed
Phase 4

A Randomized, Double-Blind, Multicenter Study Comparing the Effects of Carvedilol and Metoprolol on Glycemic Control in Hypertensive Patients With Type II Diabetes Mellitus.

GlaxoSmithKline1 site in 1 country501 target enrollmentJune 2001
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHypertension
Drugscarvedilolmetoprolol

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Hypertension
Sponsor
GlaxoSmithKline
Enrollment
501
Locations
1
Primary Endpoint
Change from baseline in HbA1c at 5 months
Status
Completed
Last Updated
11 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSitesSimilar Trials

Overview

Brief Summary

Evaluation of the effect of two different antihypertensive treatments on control of glucose in Type II diabetic patients with high blood pressure

Registry
clinicaltrials.gov
Start Date
June 2001
End Date
April 2004
Last Updated
11 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Change from baseline in HbA1c at 5 months

Time Frame: 5 months

Secondary Outcomes

  • Blood pressure at 3 and 5 months Body weight at 3 and 5 months Lab levels (glucose, insulin, triglycerides, cholesterol, and albumin:creatinine ratio) at 3 and 5 months.(5 months)

Study Sites (1)

Loading locations...

Similar Trials

Terminated
Phase 3
Efficacy and Safety of Azilsartan Medoxomil Used in Combination With Metformin in Participants With Hypertension and DiabetesHypertensionDiabetes
NCT01496430Takeda105
Completed
Phase 4
Glycemic Control Of Carvedilol Versus Metoprolol In Patients With Type II Diabetes Mellitus And HypertensionHypertension
NCT00060918GlaxoSmithKline1,210
Completed
Not Applicable
Pharmaco-epidemiological Study Describing a Population of Hypertensive Patients Treated With a Fixed-dose Combination of Telmisartan and HydrochlorothiazideHypertension
NCT02248129Boehringer Ingelheim4,255
Completed
Phase 4
A Research Study to Compare the Effect of Insulin Degludec and Insulin Glargine on Blood Sugar Levels in People With Type 2 Diabetes - the SWITCH PRO StudyDiabetes Mellitus, Type 2
NCT03687827Novo Nordisk A/S498
Unknown
Not Applicable
The Individualized Behavioral Intervention of Smartphone App in the Treatment of Type 2 Diabetes MellitusDiabetes Mellitus, Type 2
NCT03061851Qingdao Zhixin Health Technology Co., Ltd.400